BioSpace News Archive

ORIC Pharmaceuticals, Inc. today announced that management will participate in a fireside chat at the Oppenheimer 33rd Annual Healthcare Conference on Monday, March 13, 2023, at 2:00 p.m. ET.

The merger of Orthofix Medical Inc. (“Orthofix”) and SeaSpine Holdings Corporation (“SeaSpine”) became effective as of January 5, 2023.

Savara Inc. today announced that its management team will present at the Oppenheimer 33rd Annual Healthcare Conference on March 13, 2023 at 1:20pm ET.

Pipeline Therapeutics announced today that it will present a poster highlighting the preclinical profile of PIPE-791 at the Glial Biology: Functional Interactions Among Glia and Neurons, a Gordon Research Conference (GRC), being held March 5-10, 2023, in Ventura, CA.

Adial Pharmaceuticals, Inc. today provided an update on its regulatory strategy for AD04, the Company’s lead compound for the treatment of Alcohol Use Disorder (AUD).

Cellectis S.A. announced today that Calyxt, Inc. today announced operating and financial results for its fourth quarter ended December 31, 2022.

Mirati Therapeutics, Inc. will participate at the Barclays Global Healthcare Conference on March 14 at 6:00 a.m. P.T. / 9:00 a.m. E.T.

Pioneering surgical technology company Xenco Medical has been named as one of the World’s Most Innovative Companies by Fast Company Magazine in its distinguished 2023 list.

Hummingbird Bioscience, and Cancer Research Horizons, the innovation arm of Cancer Research UK (CRUK), today announced that Hummingbird Bioscience has exercised its option to license in the first-in-human (FIH) clinical trial results of HMBD-001, a differentiated and potentially best-in-class HER3-targeting antibody.

Octapharma USA presented research at the American Academy of Allergy, Asthma & Immunology Annual Meeting evaluating the efficacy and safety of cutaquig® infusions at higher infusion parameters, potentially offering greater dosing flexibility for patients.